Follow the LILLY ELI & CO stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). Market capitalisation: €1,024.5bn. The latest transaction was reported on 8 February 2016 (Cession). Among the most active insiders: Fry Stephen F. All data is openly available.
55
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
8 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate LILLY ELI & CO Buy (bullish), based on 26 analysts. Average price target: US$1,276.96.
Fundamental score
Ranked 10,138 of 29,062 companies
59.1
score / 100
Value
32
Quality
86
FCF yld0.6%
Earn yld2.0%
EV/EBITDA33.7x
ROE107%
Gross mgn83%
Net mgn32%
Debt/EBITDA1.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
LILLY ELI & CO es una empresa que cotiza en el mercado XNAS. Está involucrada en el sector de la salud, centrándose en la investigación y el desarrollo de productos farmacéuticos.